Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10705594.9Aexternal-prioritypatent/EP2401270B1/en
Application filed by Glaxo Group LimitedfiledCriticalGlaxo Group Limited
Publication of CY1115025T1publicationCriticalpatent/CY1115025T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Ενώσεις ινδαζολίου (I), μέθοδοι για την παρασκευή αυτών, ενδιάμεσες ενώσεις οι οποίες είναι χρήσιμες εις τις μεθόδους αυτές, φαρμακευτικές συνθέσεις οι οποίες περιέχουν τέτοιες ενώσεις και η χρήση αυτών εις τη θεραπεία, η οποία είναι σχετική προς τους ανταγωνιστές υποδοχέα CCR4.Indazole (I) compounds, methods for their preparation, intermediates useful in these methods, pharmaceutical compositions containing such compounds, and their use in therapy which is related to CCR4 receptor antagonists.
CY20141100001T2009-02-262014-01-03
Byzantine derivatives used as CCR4 receptor antagonists
CY1115025T1
(en)